181 related articles for article (PubMed ID: 36201890)
41. Signal-transducing adaptor molecules STAM1 and STAM2 are required for T-cell development and survival.
Yamada M; Ishii N; Asao H; Murata K; Kanazawa C; Sasaki H; Sugamura K
Mol Cell Biol; 2002 Dec; 22(24):8648-58. PubMed ID: 12446783
[TBL] [Abstract][Full Text] [Related]
42. Limiting {gamma}c expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors.
Smyth CM; Ginn SL; Deakin CT; Logan GJ; Alexander IE
Blood; 2007 Jul; 110(1):91-8. PubMed ID: 17363735
[TBL] [Abstract][Full Text] [Related]
43. IL-7R alpha gene expression is inversely correlated with cell cycle progression in IL-7-stimulated T lymphocytes.
Swainson L; Verhoeyen E; Cosset FL; Taylor N
J Immunol; 2006 Jun; 176(11):6702-8. PubMed ID: 16709829
[TBL] [Abstract][Full Text] [Related]
44. Dual roles of IL-15 in maintaining IL-7RalphalowCCR7- memory CD8+ T cells in humans via recovering the phosphatidylinositol 3-kinase/AKT pathway.
Kim HR; Hwang KA; Kang I
J Immunol; 2007 Nov; 179(10):6734-40. PubMed ID: 17982063
[TBL] [Abstract][Full Text] [Related]
45. A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia.
Akkapeddi P; Fragoso R; Hixon JA; Ramalho AS; Oliveira ML; Carvalho T; Gloger A; Matasci M; Corzana F; Durum SK; Neri D; Bernardes GJL; Barata JT
Leukemia; 2019 Sep; 33(9):2155-2168. PubMed ID: 30850736
[TBL] [Abstract][Full Text] [Related]
46. Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.
Hand TW; Cui W; Jung YW; Sefik E; Joshi NS; Chandele A; Liu Y; Kaech SM
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16601-6. PubMed ID: 20823247
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-7-induced Stat-5 acts in synergy with Flt-3 signaling to stimulate expansion of hematopoietic progenitor cells.
Åhsberg J; Tsapogas P; Qian H; Zetterblad J; Zandi S; Månsson R; Jönsson JI; Sigvardsson M
J Biol Chem; 2010 Nov; 285(47):36275-84. PubMed ID: 20829349
[TBL] [Abstract][Full Text] [Related]
48. Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.
Guo Y; Shan Q; Gong Y; Lin J; Yang X; Zhou R
Cancer Biol Ther; 2012 Nov; 13(13):1244-54. PubMed ID: 22895079
[TBL] [Abstract][Full Text] [Related]
49. BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia.
Ott CJ; Kopp N; Bird L; Paranal RM; Qi J; Bowman T; Rodig SJ; Kung AL; Bradner JE; Weinstock DM
Blood; 2012 Oct; 120(14):2843-52. PubMed ID: 22904298
[TBL] [Abstract][Full Text] [Related]
50. Extracellular adenosine regulates naive T cell development and peripheral maintenance.
Cekic C; Sag D; Day YJ; Linden J
J Exp Med; 2013 Nov; 210(12):2693-706. PubMed ID: 24145516
[TBL] [Abstract][Full Text] [Related]
51. The novel role of IL-7 ligation to IL-7 receptor in myeloid cells of rheumatoid arthritis and collagen-induced arthritis.
Chen Z; Kim SJ; Chamberlain ND; Pickens SR; Volin MV; Volkov S; Arami S; Christman JW; Prabhakar BS; Swedler W; Mehta A; Sweiss N; Shahrara S
J Immunol; 2013 May; 190(10):5256-66. PubMed ID: 23606539
[TBL] [Abstract][Full Text] [Related]
52. Epigallocatechin-3-gallate inhibits expression of receptors for T cell regulatory cytokines and their downstream signaling in mouse CD4+ T cells.
Wang J; Pae M; Meydani SN; Wu D
J Nutr; 2012 Mar; 142(3):566-71. PubMed ID: 22323768
[TBL] [Abstract][Full Text] [Related]
53. Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.
Korte A; Köchling J; Badiali L; Eckert C; Andreae J; Geilen W; Kebelmann-Betzing C; Taube T; Wu S; Henze G; Seeger K
Cytokine; 2000 Nov; 12(11):1597-608. PubMed ID: 11052810
[TBL] [Abstract][Full Text] [Related]
54. Multiple gammac-receptor expression in adult T-cell leukemia.
Baba H; Yamada Y; Mori N; Hayashibara T; Harasawa H; Tsuruda K; Sugahara K; Soda H; Takasaki Y; Tawara M; Hirakata Y; Tomonaga M; Kamihira S
Eur J Haematol; 2002 Jun; 68(6):362-9. PubMed ID: 12225394
[TBL] [Abstract][Full Text] [Related]
55. Ephrinb1 and Ephrinb2 are associated with interleukin-7 receptor α and retard its internalization from the cell surface.
Luo H; Wu Z; Qi S; Jin W; Han B; Wu J
J Biol Chem; 2011 Dec; 286(52):44976-87. PubMed ID: 22069310
[TBL] [Abstract][Full Text] [Related]
56. IL-7 downregulates IL-7Rα expression in human CD8 T cells by two independent mechanisms.
Ghazawi FM; Faller EM; Sugden SM; Kakal JA; MacPherson PA
Immunol Cell Biol; 2013 Feb; 91(2):149-58. PubMed ID: 23207282
[TBL] [Abstract][Full Text] [Related]
57. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
Puel A; Ziegler SF; Buckley RH; Leonard WJ
Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-7 in T-cell acute lymphoblastic leukemia: an extrinsic factor supporting leukemogenesis?
Barata JT; Cardoso AA; Boussiotis VA
Leuk Lymphoma; 2005 Apr; 46(4):483-95. PubMed ID: 16019476
[TBL] [Abstract][Full Text] [Related]
59. Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer.
Vudattu NK; Magalhaes I; Schmidt M; Seyfert-Margolis V; Maeurer MJ
Int J Cancer; 2007 Oct; 121(7):1512-9. PubMed ID: 17546596
[TBL] [Abstract][Full Text] [Related]
60. Differential IL-7 responses in developing human thymocytes.
Marino JH; Tan C; Taylor AA; Bentley C; Van De Wiele CJ; Ranne R; Paliotta M; Broughan TA; Teague TK
Hum Immunol; 2010 Apr; 71(4):329-33. PubMed ID: 20074604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
